Yuka Nakazawa

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Dna Methylation

Regulatory T Cells

Transcranial Magnetic Stimulation

High Throughput Sequencing

Top Venues

Nature cell biology

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuyoshi Oka, Yuka Nakazawa, Mayuko Shimada, Tomoo Ogi
Endogenous aldehyde-induced DNA-protein crosslinks are resolved by transcription-coupled repair. Nature cell biology 26 (5) (2024)
Yasuyoshi Oka, Yuka Nakazawa, Mayuko Shimada, Tomoo Ogi
Endogenous aldehyde-induced DNA-protein crosslinks are resolved by transcription-coupled repair. Nature cell biology 26 (5) (2024)
Yasuyoshi Oka, Yuka Nakazawa, Mayuko Shimada, Tomoo Ogi
Endogenous aldehyde-induced DNA-protein crosslinks are resolved by transcription-coupled repair. Nature cell biology 26 (5) (2024)
Yasuyoshi Oka, Yuka Nakazawa, Mayuko Shimada, Tomoo Ogi
Endogenous aldehyde-induced DNA-protein crosslinks are resolved by transcription-coupled repair. Nature cell biology (2024)
Yasuyoshi Oka, Yuka Nakazawa, Mayuko Shimada, Tomoo Ogi
Endogenous aldehyde-induced DNA-protein crosslinks are resolved by transcription-coupled repair. Nature cell biology 26 (5) (2024)
Yasuyoshi Oka, Yuka Nakazawa, Mayuko Shimada, Tomoo Ogi
Endogenous aldehyde-induced DNA-protein crosslinks are resolved by transcription-coupled repair. Nature cell biology 26 (5) (2024)
Akiko Tomita, Hiroyuki Sasanuma, Tomoo Owa, Yuka Nakazawa, Mayuko Shimada, Takahiro Fukuoka, Tomoo Ogi, Shinichiro Nakada
Inducing multiple nicks promotes interhomolog homologous recombination to correct heterozygous mutations in somatic cells. Nature communications 14 (1) (2023)
Chikako Senju, Yuka Nakazawa, Taichi Oso, Mayuko Shimada, Kana Kato, Michiko Matsuse, Mariko Tsujimoto, Taro Masaki, Yasushi Miyazaki, Satoshi Fukushima, Satoshi Tateishi, Atsushi Utani, Hiroyuki Murota, Katsumi Tanaka, Norisato Mitsutake, Shinichi Moriwaki, Chikako Nishigori, Tomoo Ogi
Deep intronic founder mutations identified in the ERCC4 / XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum. Proceedings of the National Academy of Sciences of the United States of America 120 (27) (2023)
Chikako Senju, Yuka Nakazawa, Taichi Oso, Mayuko Shimada, Kana Kato, Michiko Matsuse, Mariko Tsujimoto, Taro Masaki, Yasushi Miyazaki, Satoshi Fukushima, Satoshi Tateishi, Atsushi Utani, Hiroyuki Murota, Katsumi Tanaka, Norisato Mitsutake, Shinichi Moriwaki, Chikako Nishigori, Tomoo Ogi
Deep intronic founder mutations identified in the ERCC4 / XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum. Proceedings of the National Academy of Sciences of the United States of America 120 (27) (2023)
Chikako Senju, Yuka Nakazawa, Taichi Oso, Mayuko Shimada, Kana Kato, Michiko Matsuse, Mariko Tsujimoto, Taro Masaki, Yasushi Miyazaki, Satoshi Fukushima, Satoshi Tateishi, Atsushi Utani, Hiroyuki Murota, Katsumi Tanaka, Norisato Mitsutake, Shinichi Moriwaki, Chikako Nishigori, Tomoo Ogi
Deep intronic founder mutations identified in the ERCC4 / XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum. Proceedings of the National Academy of Sciences of the United States of America 120 (27) (2023)